Abstract P2-04-27: CTLA-4 and PD-1 checkpoint inhibitors enhance individually tailored adaptive anti-tumor immune responses to overcome tumor immunosuppression and effectively treat triple-negative breast cancer

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Hartman, Z; Crosby, E; Wei, J-P; Yang, X-Y; Lei, G-J; Wang, T; Liu, C-X; Agarwal, P; Morse, M; Lyerly, H

Published Date

  • February 15, 2017

Published In

Volume / Issue

  • 77 / 4 Supplement

Start / End Page

  • P2-04-27 - P2-04-27

Electronic International Standard Serial Number (EISSN)

  • 1538-7445

International Standard Serial Number (ISSN)

  • 0008-5472

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.SABCS16-P2-04-27